ZBH - Zimmer Biomet Holdings - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98956P1021
Hip, Knee, Sports Medicine, Biologics, Trauma, Orthopedic, Surgical
Zimmer Biomet Holdings Inc is a global medical technology company that designs, manufactures, and markets a wide range of orthopedic reconstructive products. These products include knee and hip replacements, sports medicine solutions, biologics, foot and ankle implants, extremities products, and trauma devices.
The company's product portfolio also features craniomaxillofacial and thoracic solutions, which are used to reconstruct the face and skull, as well as stabilize the chest bones after open heart surgery, trauma, or to correct deformities. Additionally, Zimmer Biomet offers robotic, surgical, and bone cement products that are used in various orthopedic procedures.
Zimmer Biomet's products and solutions are designed to treat patients with disorders or injuries affecting bones, joints, or supporting soft tissues. The company's customers include orthopedic surgeons, neurosurgeons, hospitals, distributors, dealers, and other healthcare professionals. Zimmer Biomet also partners with agents, healthcare purchasing organizations, and buying groups to deliver its products and solutions to the market.
With a rich history dating back to 1927, Zimmer Biomet has evolved over the years to become a leading player in the medical technology industry. The company changed its name from Zimmer Holdings Inc to Zimmer Biomet Holdings Inc in June 2015, following its merger with Biomet Inc. Today, Zimmer Biomet is headquartered in Warsaw, Indiana, and operates globally, with a strong commitment to innovation, quality, and customer satisfaction.
For more information about Zimmer Biomet's products, solutions, and services, please visit their website at https://www.zimmerbiomet.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
ZBH Stock Overview
Market Cap in USD | 21,414m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2001-07-25 |
ZBH Stock Ratings
Growth 5y | -23.5 |
Fundamental | 27.5 |
Dividend | 45.9 |
Rel. Performance vs Sector | -2.46 |
Analysts | 3.45/5 |
Fair Price Momentum | 95.18 USD |
Fair Price DCF | 126.09 USD |
ZBH Dividends
Dividend Yield 12m | 0.91% |
Yield on Cost 5y | 0.75% |
Dividends CAGR 5y | 0.61% |
Payout Consistency | 98.4% |
ZBH Growth Ratios
Growth 12m | -12.11% |
Growth Correlation 12m | -8% |
Growth Correlation 3m | 37% |
CAGR 5y | -3.94% |
CAGR/Mean DD 5y | -0.18 |
Sharpe Ratio 12m | -0.78 |
Alpha vs SP500 12m | -39.90 |
Beta vs SP500 5y weekly | 1.09 |
ValueRay RSI | 22.00 |
Volatility GJR Garch 1y | 20.43% |
Price / SMA 50 | -4.22% |
Price / SMA 200 | -10.61% |
Current Volume | 1258.6k |
Average Volume 20d | 1388.2k |
External Links for ZBH Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of September 12, 2024, the stock is trading at USD 105.15 with a total of 1,258,600 shares traded.
Over the past week, the price has changed by -8.15%, over one month by -1.73%, over three months by -3.52% and over the past year by -12.83%.
According to ValueRays Forecast Model, ZBH Zimmer Biomet Holdings will be worth about 104.6 in September 2025. The stock is currently trading at 105.15. This means that the stock has a potential downside of -0.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 125 | 18.9 |
Analysts Target Price | 143.8 | 36.7 |
ValueRay Target Price | 104.6 | -0.55 |